Cargando…
USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin
Background: The evolution of adriamycin (ADR) resistance in the treatment of breast cancer often leads to a poor prognosis in patients. Ubiquitin-specific peptidase 37 (USP37) has been recently identified as a modulator in regulating the stemness of breast cancer cells, but its underlying mechanism...
Autores principales: | Qin, Tao, Cui, Xin-Ye, Xiu, Hao, Huang, Chao, Sun, Zhen-Ni, Xu, Xiao-Mei, Li, Lian-Hong, Yue, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757157/ https://www.ncbi.nlm.nih.gov/pubmed/33390801 http://dx.doi.org/10.7150/ijms.54301 |
Ejemplares similares
-
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
por: Qin, Tao, et al.
Publicado: (2018) -
Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
por: Qin, Tao, et al.
Publicado: (2021) -
ATRA attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin
por: Zhang, Lei, et al.
Publicado: (2018) -
Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin
por: Liu, Huimin, et al.
Publicado: (2020) -
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
por: Gao, Jian, et al.
Publicado: (2018)